| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |